Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis

por Sellam, Jérémie, Rivière, Elodie, Courties, Alice, Rouzaire, Paul-Olivier, Tolusso, Barbara, Vital, Edward M., Emery, Paul, Ferracioli, Gianfranco, Soubrier, Martin, Ly, Bineta, Chavez, Houria Hendel, Taoufik, Yassine, Dougados, Maxime, Mariette, Xavier
Publicado 2017